New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (China), China, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
74%
Total
Publications
141
Total Open
Publications
105
Total
Citations
3.7K
Open Access
Percentage
74%
Total
Publications
141
Total Open
Publications
105
Total
Citations
3.7K
Breakdown
Publisher Open
16%
Both
43%
Other Platform Open
3%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 70%
39
Hybrid 21%
12
No Guarantees 9%
5
Other Platform Open
Domain 89%
41
Other Internet 15%
7
Institution 13%
6
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 41 |
DOI | Other Internet | 6 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 5 |
Unknown Repository | Other Internet | 1 |
University of Nottingham - Repository@Nottingham | Institution | 1 |
Leibniz Universität Hannover - Institutional Repository of Leibniz Universität Hannover | Institution | 1 |
Europe PMC | Domain | 1 |
Boston University - OpenBU/Boston University Institutional Repository | Institution | 1 |